Physician profile
Coty P Ho
NPI 1497808950
$1,117.24
in general payments reported to CMS, 2019-2025
26 companies · $50.16 in 2025
The $50.16 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $972 · 2020: $72.37 · 2024: $22.67 · 2025: $50.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $72.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $72.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $153.09 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $134.23 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $78.09 | 2019 | |
| Abbvie INC. | $72.83 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $72.77 | 2019 | |
| Mylan Institutional INC. | $71.07 | 2019 | |
| Amgen INC. | $67.05 | 2019 | |
| Sun Pharmaceutical Industries INC. | $66.74 | 2019 | |
| Janssen Scientific Affairs, LLC | $55.27 | 2019 | |
| Genzyme Corporation | $42.13 | 2019 | |
| Dendreon Pharmaceuticals LLC | $34.88 | 2019 | |
| Array Biopharma INC | $27.26 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.32 | 2019-2020 | |
| Daiichi Sankyo INC. | $24.81 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $24.77 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verastem, INC. | $23.95 | 2019 | |
| Lilly USA, LLC | $22.60 | 2019 | |
| Exelixis INC. | $22.37 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $20.78 | 2019 | |
| Pfizer INC. | $16.33 | 2019 | |
| Monteris Medical Corporation | $16.12 | 2019 | |
| Foundation Medicine, INC. | $15.91 | 2019 | |
| Puma Biotechnology, INC. | $14.95 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.92 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Coty Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.